We missed you too. Sign up to our newsletter, and follow us on Instagram and Twitter, so you always know where to find us.
The human body needs a continuous flow of blood through it to keep us alive.
If we get an injury, like a cut, blood clots help that injury to heal. They act kind of like a plug to stop blood leaking out.
The body usually breaks down the clot once that injury has healed. But sometimes that doesn’t happen, and those blood clots can form inside arteries or veins.
Kind of like what happened with the ship that got stuck in the Suez Canal.
Mysterious structures in Saudi Arabia thousands of years older than Stonehenge, pyramids msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
Emyria to focus on initiating and completing pivotal clinical trials for EMD-003 program and advancing EMD-004 program
EMD-003 is being developed to reduce anxiety, depression and stress symptoms while the company is also advancing EMD-004 targeting irritable bowel syndrome. The company secured access to a unique CBD dose product via a partnership with Cann Group
Emyria Ltd (ASX:EMD) will continue its focus on initiating and completing pivotal clinical trials for the EMD-003 program, seeking to register a cannabinoid-based medicine with a unique capsule dose form to reduce symptoms of anxiety, depression and stress.
The data-backed drug development company is also advancing the EMD-004 program targeting irritable bowel syndrome and scoping pipeline expansion therapeutically (with psychedelic-assisted therapy) and geographically with the US Food and Drug Administration (FDA) pathways.
Date Time
2020 RAI Awardees Announced
Four Australian medical researcher programs have been awarded a CSL Research Acceleration Initiative partnership, including a $500,000 AUD investment in each program over two years, to fast-track the discovery of innovative biotherapies to address unmet patient needs.
The CSL Research Acceleration Initiative establishes partnerships between CSL and global research organisations and includes funding as well as access to CSL R&D experts.
Marthe D’Ombrain, CSL’s Head of Global Research Innovation said, “Australian researchers have an excellent reputation globally for producing high quality, novel research. The CSL Research Acceleration Initiative is designed to enhance research commercialisation through partnerships in promising discovery programs.